Are you Dr. Schmieg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1430 Tulane Ave
Sl79
New Orleans, LA 70112Phone+1 504-988-5224Fax+1 504-988-2420
Summary
- Dr. John Schmieg III, MD is a board certified pathologist in New Orleans, Louisiana. He is currently licensed to practice medicine in Louisiana and Pennsylvania. He is affiliated with University Medical Center and is an Assistant Professor at Tulane University School of Medicine.
Education & Training
- Johns Hopkins UniversityFellowship, Hematopathology, 2010 - 2011
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2006 - 2010
- New York University School of MedicineClass of 2006
Certifications & Licensure
- LA State Medical License 2011 - 2025
- PA State Medical License 2009 - 2014
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 301 citationsSuperior Protection against Malaria and Melanoma Metastases by a C-glycoside Analogue of the Natural Killer T Cell Ligand α-GalactosylceramideJohn Schmieg, Guangli Yang, Richard W. Franck, Moriya Tsuji
The Journal of Experimental Medicine. 2003-12-01 - 263 citationsNatural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria VaccinesGloria Gonzalez-Aseguinolaza, Luc Van Kaer, Cornelia C. Bergmann, James M. Wilson, John Schmieg
The Journal of Experimental Medicine. 2002-03-04 - 144 citationsThe C-Glycoside Analogue of the Immunostimulant α-Galactosylceramide (KRN7000): Synthesis and Striking Enhancement of ActivityGuangli Yang, John Schmieg, Moriya Tsuji, Richard W. Franck
Angewandte Chemie. 2004-07-19